Safety study of REGN22044 in healthy adults
This is an early-stage safety study testing a new experimental drug called REGN22044 in people with no serious health conditions. Researchers want to understand how safe the drug is, how well people tolerate it, and how the body processes it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in overall good health with no serious heart, lung, liver, kidney, stomach, hormone, blood, mental health, or nervous system conditions
- You have not had fever with infection or active infections treated with antibiotics, antivirals, or antifungals in the past 8 weeks
- You do not have active or latent tuberculosis (TB)
- You are not taking any prescription medications, over-the-counter medications, or supplements for at least 14 days before the study (some exceptions may apply)
- You do not have a history of frequent or recurring infections
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This trial tests a new medicine to see how the body handles it and whether it is safe. It is for healthy people, not for treating a disease, and helps researchers decide if the drug can move to the next stage of testing.
This trial tests a new medicine called RO7806881 in healthy volunteers to see if it is safe, what dose is best, and how the body handles it. It is an early study that helps researchers decide if the drug should be tested in people with a disease.
This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.
This trial tests a new medicine called TRT-448 in healthy adults to see if it is safe and how the body processes it. It is a first-in-human study, meaning the drug has not been given to people before.
Hear when a new Healthy Volunteer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.